Case Report: Complete remission in a neonate with high-risk neuroblastoma harboring MYCN amplification and 1p deletion: a case for aggressive early intervention, and literature review. [PDF]
Front PediatrGabitova NK +6 more
europepmc +1 more source
Effect of <i>MYCN</i> Amplification on Tumor Response and Recurrence in Patients With Stage IV Neuroblastoma. [PDF]
JCO Precis OncolMatser YAH +12 more
europepmc +1 more source
Development of a prognostic model for overall survival in neuroblastoma based on Schwann cell-specific genes, clinical predictors, and MYCN amplification. [PDF]
Transl Cancer ResLi Z, Liu J, Wu Y.
europepmc +1 more source
Event-free survival in neuroblastoma with MYCN amplification and deletion of 1p or 11q may be associated with altered immune status. [PDF]
BMC CancerWei Z, Gong B, Li X, Chen C, Zhao Q.
europepmc +1 more source
Retinoblastoma with MYCN Amplification Diagnosed from Cell-Free DNA in the Aqueous Humor. [PDF]
Ocul Oncol PatholJoseph S +8 more
europepmc +1 more source
Hypoxia-Dependent Expression of TG2 Isoforms in Neuroblastoma Cells as Consequence of Different MYCN Amplification Status. [PDF]
Int J Mol Sci, 2020 Currò M +9 more
europepmc +1 more source
Druggable epigenetic suppression of interferon-induced chemokine expression linked to MYCN amplification in neuroblastoma. [PDF]
J Immunother Cancer, 2021 Seier JA +10 more
europepmc +1 more source
Differential Clinical Significance of Neurotrophin-3 Expression according to MYCN Amplification and TrkC Expression in Neuroblastoma. [PDF]
J Korean Med Sci, 2019 Seo E +9 more
europepmc +1 more source